These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16434309)

  • 21. Protein kinases are involved in the cardioprotective effects activated by platelet glycoprotein IIb/IIIa inhibitor tirofiban at reperfusion in rats in vivo.
    Chang ST; Yang YT; Chu CM; Pan KL; Hsu JT; Hsiao JF; Lin YS; Chung CM
    Eur J Pharmacol; 2018 Aug; 832():33-38. PubMed ID: 29778748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo.
    Wang J; Yang H; Hu X; Fu W; Xie J; Zhou X; Xu W; Jiang H
    J Surg Res; 2013 Aug; 183(2):509-16. PubMed ID: 23531454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
    Penna C; Settanni F; Tullio F; Trovato L; Pagliaro P; Alloatti G; Ghigo E; Granata R
    Endocrinology; 2013 Apr; 154(4):1624-35. PubMed ID: 23417421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin reduces PERK-eIF2α-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia-reperfusion injury: role of RISK and SAFE pathways interaction.
    Yu L; Li B; Zhang M; Jin Z; Duan W; Zhao G; Yang Y; Liu Z; Chen W; Wang S; Yang J; Yi D; Liu J; Yu S
    Apoptosis; 2016 Jul; 21(7):809-24. PubMed ID: 27170343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
    Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
    Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
    Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.
    Ramos-Nino ME; Blumen SR; Sabo-Attwood T; Pass H; Carbone M; Testa JR; Altomare DA; Mossman BT
    Am J Respir Cell Mol Biol; 2008 Feb; 38(2):209-17. PubMed ID: 17872495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
    Liu S; Ai Q; Feng K; Li Y; Liu X
    Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild hypothermia pretreatment protects against liver ischemia reperfusion injury via the PI3K/AKT/FOXO3a pathway.
    Xiao Q; Ye Q; Wang W; Xiao J; Fu B; Xia Z; Zhang X; Liu Z; Zeng X
    Mol Med Rep; 2017 Nov; 16(5):7520-7526. PubMed ID: 28944825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
    Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
    Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway.
    Vilahur G; Cubedo J; Casani L; Padro T; Sabate-Tenas M; Badimon JJ; Badimon L
    Eur Heart J; 2013 Jul; 34(27):2082-93. PubMed ID: 22851653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RP105-PI3K-Akt axis: A potential therapeutic approach for ameliorating myocardial ischemia/reperfusion injury.
    Guo X; Jiang H; Chen J
    Int J Cardiol; 2016 Mar; 206():95-6. PubMed ID: 26785032
    [No Abstract]   [Full Text] [Related]  

  • 34. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?
    Mocanu MM; Yellon DM
    Br J Pharmacol; 2007 Apr; 150(7):833-8. PubMed ID: 17293884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.
    Stommel JM; Kimmelman AC; Ying H; Nabioullin R; Ponugoti AH; Wiedemeyer R; Stegh AH; Bradner JE; Ligon KL; Brennan C; Chin L; DePinho RA
    Science; 2007 Oct; 318(5848):287-90. PubMed ID: 17872411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.